Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phage Therapy against Staphylococcus aureus: Selection and Optimization of Production Protocols of Novel Broad-Spectrum Silviavirus Phages

6 Sept 2022

Abstract excerpt

Background: Phage therapy a promising antimicrobial strategy to address antimicrobial resistance for infections caused by the major human pathogen Staphylococcus aureus. Development of therapeutic phages for human use should follow pharmaceutical standards, including selection of strictly lytic bacteriophages with high therapeutic potential and optimization of their production process. Results: Here, we describe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Bacteriophages and microbial interactions
Share to Microbial infections and disease research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36145633
DOI: 10.3390/pharmaceutics14091885

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phage Therapy against Staphylococcus aureus: Selection and Optimization of Production Protocols of Novel Broad-Spectrum Silviavirus PhagesPMID 36145633Read ↗

Isolation and characterisation of a novel Silviavirus bacteriophage promising antimicrobial agent against methicillin-resistant Staphylococcus aureus infectionsSemantic proximity Read ↗

Phenotypic and Genotypic Characterization of Novel Polyvalent Bacteriophages With Potent In Vitro Activity Against an International Collection of Genetically Diverse Staphylococcus aureus.Semantic proximity Read ↗

Novel Silviavirus phages with broad-host-range activity against methicillin resistant Staphylococcus aureus from seafood: comprehending the phenotypic and genotypic variability.Semantic proximity Read ↗

Isolation and characterization of methicillin-resistant Staphylococcus aureus phage SPB against MRSA planktonic cells and biofilmSemantic proximity Read ↗

Specification of Bacteriophage Isolated Against Clinical Methicillin-Resistant Staphylococcus AureusSemantic proximity Read ↗

Broad-range lytic bacteriophages that kill Staphylococcus aureus local field strainsSemantic proximity Read ↗

Virological and Pharmaceutical Properties of Clinically Relevant PhagesSemantic proximity Read ↗

Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus ?Semantic proximity Read ↗

Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus.Semantic proximity Read ↗

StAP1 phage: an effective tool for treating methicillin-resistant Staphylococcus aureus infectionsSemantic proximity Read ↗

CRISPR-Cas9 enables efficient genome engineering of the strictly lytic, broad host-range staphylococcal bacteriophage KSemantic proximity Read ↗

A new bacteriophage infecting Staphylococcus epidermidis with potential for removing biofilms by combination with chimeric lysin CHAPSH3b and vancomycinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.